These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 11570941)

  • 1. Diagnosis of influenza in the community: relationship of clinical diagnosis to confirmed virological, serologic, or molecular detection of influenza.
    Zambon M; Hays J; Webster A; Newman R; Keene O
    Arch Intern Med; 2001 Sep; 161(17):2116-22. PubMed ID: 11570941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial.
    Hedrick JA; Barzilai A; Behre U; Henderson FW; Hammond J; Reilly L; Keene O
    Pediatr Infect Dis J; 2000 May; 19(5):410-7. PubMed ID: 10819336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.
    Hayden FG; Osterhaus AD; Treanor JJ; Fleming DM; Aoki FY; Nicholson KG; Bohnen AM; Hirst HM; Keene O; Wightman K
    N Engl J Med; 1997 Sep; 337(13):874-80. PubMed ID: 9302301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group.
    Hayden FG; Gubareva LV; Monto AS; Klein TC; Elliot MJ; Hammond JM; Sharp SJ; Ossi MJ;
    N Engl J Med; 2000 Nov; 343(18):1282-9. PubMed ID: 11058672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomized, double-blind, placebo-controlled European study.
    Mäkelä MJ; Pauksens K; Rostila T; Fleming DM; Man CY; Keene ON; Webster A
    J Infect; 2000 Jan; 40(1):42-8. PubMed ID: 10762110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group.
    Lancet; 1998 Dec; 352(9144):1877-81. PubMed ID: 9863784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical signs and symptoms predicting influenza infection.
    Monto AS; Gravenstein S; Elliott M; Colopy M; Schweinle J
    Arch Intern Med; 2000 Nov; 160(21):3243-7. PubMed ID: 11088084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spotlight on zanamivir in influenza.
    Cheer SM; Wagstaff AJ
    Am J Respir Med; 2002; 1(2):147-52. PubMed ID: 14720068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of zanamivir in patients with influenza--impact of age, severity of infections and specific risk factors.
    Höffken G; Gillissen A
    Med Microbiol Immunol; 2002 Dec; 191(3-4):169-73. PubMed ID: 12458354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zanamivir: a significant reduction in viral load during treatment in military conscripts with influenza.
    Puhakka T; Lehti H; Vainionpää R; Jormanainen V; Pulkkinen M; Sharp S; Kerr C; Dempsey M; Ring CJ; Ward C; Tisdale M
    Scand J Infect Dis; 2003; 35(1):52-8. PubMed ID: 12685885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zanamivir for the treatment of influenza A and B infection in high-risk patients: a pooled analysis of randomized controlled trials.
    Lalezari J; Campion K; Keene O; Silagy C
    Arch Intern Med; 2001 Jan; 161(2):212-7. PubMed ID: 11176734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, placebo-controlled studies of inhaled zanamivir in the treatment of influenza A and B: pooled efficacy analysis.
    Monto AS; Webster A; Keene O
    J Antimicrob Chemother; 1999 Nov; 44 Suppl B():23-9. PubMed ID: 10877459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections.
    Monto AS; Fleming DM; Henry D; de Groot R; Makela M; Klein T; Elliott M; Keene ON; Man CY
    J Infect Dis; 1999 Aug; 180(2):254-61. PubMed ID: 10395837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of zanamivir on antibiotic use for respiratory events following acute influenza in adolescents and adults.
    Kaiser L; Keene ON; Hammond JM; Elliott M; Hayden FG
    Arch Intern Med; 2000 Nov; 160(21):3234-40. PubMed ID: 11088083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coadministration of orally inhaled zanamivir with inactivated trivalent influenza vaccine does not adversely affect the production of antihaemagglutinin antibodies in the serum of healthy volunteers.
    Webster A; Boyce M; Edmundson S; Miller I
    Clin Pharmacokinet; 1999; 36 Suppl 1():51-8. PubMed ID: 10429840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trial.
    LaForce C; Man CY; Henderson FW; McElhaney JE; Hampel FC; Bettis R; Kudule L; Harris J; Yates P; Tisdale M; Webster A
    Clin Ther; 2007 Aug; 29(8):1579-90; discussion 1577-8. PubMed ID: 17919541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of zanamivir treatment on the early immune response to influenza vaccination.
    Cox RJ; Mykkeltvedt E; Sjursen H; Haaheim LR
    Vaccine; 2001 Sep; 19(32):4743-9. PubMed ID: 11535325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison study of a real-time reverse transcription polymerase chain reaction assay with an enzyme immunoassay and shell vial culture for influenza A and B virus detection in adult patients].
    Reina J; Plasencia V; Leyes M; Nicolau A; Galmés A; Arbona G
    Enferm Infecc Microbiol Clin; 2010 Feb; 28(2):95-8. PubMed ID: 19477042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza.
    Hayden FG; Treanor JJ; Betts RF; Lobo M; Esinhart JD; Hussey EK
    JAMA; 1996 Jan 24-31; 275(4):295-9. PubMed ID: 8544269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zanamivir prophylaxis: an effective strategy for the prevention of influenza types A and B within households.
    Monto AS; Pichichero ME; Blanckenberg SJ; Ruuskanen O; Cooper C; Fleming DM; Kerr C
    J Infect Dis; 2002 Dec; 186(11):1582-8. PubMed ID: 12447733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.